James Belk

James Belk is a seasoned professional with extensive experience in project management and regulatory strategic planning within the pharmaceutical and biotechnology sectors. Currently serving as a Consultant in Development and Technical Operations at Jazz Pharmaceuticals since November 2017, James leads global project management for cross-functional teams focused on innovative therapeutic developments in Hematology/Oncology and Sleep. Previous roles include Senior Consultant at EnDev Laboratories™, Associate Director at ABBVIE, and Senior Program Manager at Amgen, where James managed complex clinical development programs and ensured compliance with regulatory standards. James's career also includes strategic planning and program management positions at Pfizer and Johnson and Johnson MD&D. James holds an MBA from Columbia Business School and a BE in Chemical Engineering from Vanderbilt University.